Atorvastatin Per recalls
The FDA has published 2 recalls involving Atorvastatin Per since 2012. The latest was reported on 5 Mar 2014. Most were for packaging defects. Recalls usually affect specific lots, not every bottle on the market. Check the lot number on each recall page before acting.
Total recalls2since 2012
Last 12 months0reported
Class I00% of total
Ongoing0latest 5 Mar 2014
Recalls per month, last 24 months
click a bar for that monthSeverity split
Class I 0 0%Class II 2 100%Class III 0 0%
Why atorvastatin per is recalled
Companies
By year
All atorvastatin per recalls, newest first
2 total| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS II | Atorvastatin Calcium Tablets recalled by Ranbaxy | Ranbaxy | Packaging Defects | Nationwide |
| Drug | CLASS II | Atorvastatin Calcium Tablets recalled by Ranbaxy | Ranbaxy | Packaging Defects | Nationwide |
Should you stop taking Atorvastatin Per?
Not on your own. Most recalls affect specific lots from one manufacturer, and stopping a prescription suddenly can be riskier than the defect. Check your lot number and NDC against the recall, then call the pharmacy that dispensed it for a replacement.